Please login first

7th International Electronic Conference on Medicinal Chemistry

Part of the International Electronic Conference on Medicinal Chemistry series
1–30 Nov 2021

Medicinal Chemistry, Pharmacokinetics and Pharmacodynamics, Drug Discovery and Development, Radiopharmaceutical Sciences, Drug Delivery
Share: Share in Email Share in Twitter Share in Facebook Share in LinkedIn Share in Whatsapp Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Contact Us


On behalf of the conference team of the 7th International Electronic Conference on Medicinal Chemistry, we would like to thank you for your participation by sending your contributions, being posters, slideshows or flash communications. We hope you've enjoyed it!

Winner Announcement

On behalf of the chair of the 7th International Electronic Conference on Medicinal Chemistry (ECMC-7), we are pleased to announce the winners of the Conference Award:
Best Poster Award
- Pedro Sobral et al., "Novel A-ring cleaved glycyrrhetinic acid derivatives: Synthesis and evaluation of antiproliferative activity".
Pedro Sobral is a second-year Ph.D. student in Pharmaceutical Sciences, specialty in Pharmaceutical Chemistry, in the group of Prof. Jorge Salvador at Faculty of Pharmay of University of Coimbra (Portugal). Pedro’s doctoral research is centered on the development of novel semi-synthetic molecules with anticancer activity, and he has already published 2 review articles in specialized journals. Pedro holds an Integrated Master’s degree in Pharmaceutical Sciences (2018) from the same institution.
Best Slideshow Award
- Fernando Durães et al., "Marine-derived fungi as a source of potential antimicrobial adjuvants".
The presenting author, Fernando Durães is a Ph.D. student in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Porto. His doctoral research focuses on the development of small molecules with a potential to circumvent bacterial resistance mechanisms. The authors of this presentation are engaged in a multidisciplinary project, aiming to discover new antibacterial molecules from marine sources and/or compounds that can inhibit bacterial efflux pumps. The project involves various scientific areas, from medicinal chemistry, microbiology, toxicology to molecular biology, through a partnership between the University of Porto - CIIMAR (Interdisciplinary Centre of Marine and Environmental Research), Portugal and the University of Szeged, Hungary, both of which are members of the European University Alliance for Global Health (EUGLOH).
Best Flash Communication Award
- Vera M. S. Isca et al., "Inhibition of P-glycoprotein activity to overcome multidrug resistance in cancer with new diterpene royleanones from Plectranthus spp".
Currently a third-year Ph.D. student at the PhD Program in Pharmacy, a collaboration of Faculty of Pharmacy, University of Lisbon and CBIOS - Universidade Lusófona de Humanidades e Tecnologias, financed by FCT. Vera's doctoral research is focus on the isolation, hemi-synthesis and biological evaluation of abietane diterpenoids from Plectranthus grandidentatus for cancer therapy. BSc in Biochemistry from the University of Beira Interior in 2010 and MSc in Organic Chemistry and Natural Products from the University of Aveiro in 2013.

Best Communication Award

- Claudia Riccardi et al., "Cyclic and pseudocyclic thrombin binding aptamer analogues as improved anticoagulant agents".

Claudia Riccardi is currently recipient of a postdoctoral fellowship granted by “Fondazione Umberto Veronesi”, under the supervision of Prof. Daniela Montesarchio. She obtained her degree with honors at the age of 23 in Chemistry and Pharmaceutical Technologies at Federico II University of Naples in 2013. She got her Ph.D. in Chemical Sciences in 2017 and then continued her research activities under the supervision of Prof. Montesarchio with fellowships granted by AIRC (Italian Association for the Research on Cancer). Her research interests are mainly devoted to the design, synthesis, and characterization of Ru(III) and Pt(II) complexes as potential anticancer compounds, as well as G-quadruplex-forming aptamers with potential anticancer or anticoagulant properties. She also studied multifunctional nanosystems incorporating anticancer metal-based drugs and/or aptamers for theranostic applications. She was recipient of the “Salvatore Venuta fellowship 2019” prize in Nanomedicine and of two “Best PhD thesis” prizes. She is coauthor of 32 scientific articles published in the period 2015–2021 in international, peer‐review journals, and of ca. 20 oral and poster communications presented at international and national conferences.

Best Invited Lecture

- Beatriz Berzal-Herranz, Cristina Romero-López et al., "The 3’UTR of WNV genome is an excellent target for antiviral drugs".

Alfredo Berzal-Herranz received his PhD in Molecular Biology from the Autónoma University of Madrid (1990). After a brief stay at the Department of Microbiology, of the University of Uppsala (Sweden), he moved to the Department of Microbiology, College of Medicine of the University of Vermont (USA). In 1993 he returned to Spain, joining the Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN), located in the city of Granada. The IPBLN belongs to the Spanish National Research Council (CSIC), where he established his own research group and chaired the Department of Molecular Biology. From November 2005 to March 2014 was the Director of the Institute (IPBLN-CSIC). He is the author of about 100 research articles and book chapters and has edited four special research issues. He is or has been a member of the Editorial Board of more than 15 research journals. His research group is currently interested in understanding the structure/function relationship of viral RNA genomes. He is pursuing the identification of the molecular mechanisms used by the RNA viruses to store all necessary genetic information and studying the potential use of genomic RNA structural domains as potential antiviral targets. In addition, his group is interested in the design and characterization of antiviral RNA molecules (Aptamers, antisense, ribozymes).

Cristina Romero-López received her PhD degree in Biochemistry and Molecular Biology by the University of Granada in Nov 2005. The thesis project was focused on developing new RNA-based tools able to interfere with the hepatitis C virus translation. An additional point was to make use of these compounds as molecular tools with the aim of studying the functionality of conserved regions in viral RNA genomes. Since then, she has been working as post-doctoral researcher in the Dr. Berzal-Herranz’s lab, in the Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN), located in the city of Granada (Spain). Throughout these years, her scientific interest has been focused in the RNA structural biology, moving from the research with small catalytic RNA molecules to current investigations about the functionality of conserved structural domains in viral RNA genomes, as well as their implications in virus progression and infectivity. These studies have promoted the implementation of complex high-throughput techniques for the analysis of the RNA folding. During her scientific career she has participated in eighteen research projects, supported by different national and international agencies. She has published around 50 research manuscripts and book chapters, as well as around 80 communications in national and international meetings. She has supervised six master theses and four graduate theses. Currently, she is a member of the editorial board of different research journals.

One free 1-day hands on/testing using microwaves offered by Microwave Technologies Consulting

- Marc Le Borgne et al., "Triazole-indole hybrid molecules as antifungal agents: Design, synthesis and biological activity, and beyond".

Marc Le Borgne obtained his Ph.D. in medicinal chemistry under the supervision of Prof. Guillaume Le Baut at the University of Nantes (France) in 1997. He began his research and academic career in the School of Pharmacy at the University of Nantes. In 2008, he moved to the Université Claude Bernard Lyon 1 as a full professor in medicinal chemistry. He is currently a researcher in the Team Small Molecules for Biological Targets (Cancer Research Center of Lyon). His research interests focus on the design and synthesis of bioactive small molecules as anti-infective compounds or kinase-targeted anticancer therapeutic agents. Collaborative work remains at the heart of his quality research work.

One registration seat to an upcoming Simulations Plus workshop

- Radu Tamaian et al., "Rational design of new antipsychotic virtual derivatives with improved ADMET properties and high binding activity".

Principal Investigator at the National Institute for Research and Development for Cryogenic and Isotopic Technologies – ICSI Rm. Vâlcea. My expertise is in bioinformatics and cheminformatics, with a wide research area including computer-aided drug design (CADD), computational (eco)toxicology, in silico nutrigenomics, and blockchain-enabled healthcare. Outside the lab, as the National Contact Point (NCP), I was involved in coordination and support actions for the EU research infrastructures (included in the ESFRI Roadmap) during The 7th Framework Programme of the European Commission.

Welcome from the Chair

Dear Colleagues,

Our series of International Electronic Conferences on Medicinal Chemistry has now become an unmissable event in the field. November is booked in the agenda of all scientists working in drug sciences, and November 2021 will not be an exception.

Thus, on behalf of the MDPI journal Pharmaceuticals and of the Scientific Committee, I am delighted to welcome you to this 2021 edition.

If you are not familiar with the series, you could ask: why to participate? The answer is simply because this platform aims to bring together scientists from all over the world. It gives students, researchers, and experts the opportunity to share their results and exchange their ideas in medicinal chemistry, in the broad sense of the domain. In addition, there is no need to worry about safety, time off, flights, or hotels. Indeed, this is a virtual event. And guess what? It is, again, absolutely free of charge for authors and visitors as well.

If you are familiar with the series, then, I would like to thank you for your confidence all through the previous years. The success of the series would not have been possible without you, your contribution, and your support.

Ready to join us? Log in, submit your abstract, and enjoy the Conference!

Conference Chairs

Editor-in-Chief of Pharmaceuticals, Former Head of the Department of Organic Chemistry, University of Mons-UMONS, Belgium

Conference Scientific Committee

Università degli Studi di Urbino Carlo Bo, Urbino, Italy

Research Keywords
medicinal chemistry; drug design; cannabinoids; sugar-based surfactants

Dipartimento di Farmacia, Università degli Studi “G. d'Annunzio”, Chieti, Italy

Research Keywords
aromatase inhibitors; bioactive compounds; small molecules; anticancer activity; medicinal chemistry; synthesis; drug discovery; PPAR agonists and antagonists; antiproliferative agents; nitric oxide synthase inhibitors

Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy

Formerly professor at the Haute Ecole Provinciale de Hainaut-Condorcet, Saint-Ghislain, Belgium

Research Keywords
medicinal chemistry; organic synthesis; parasitic diseases; orphan drugs

Dipartimento di Scienze Chimiche e Geologiche, Università di Cagliari, Monserrato, CA, Italy

Irma Lerma Rangel College of Pharmacy, Department of Pharmaceutical Sciences, Texas A&M Health Science Center, Texas A&M University, USA

Departamento de Química e Bioquímica e Centro de Química e Bioquímica, Universidade de Lisboa, Lisboa, Portugal

Universidade Federal do Rio de Janeiro, IPPN, CCS, Rio de Janeiro, Brazil

Research Keywords
molecular modeling; computer-aided drug design; bioinformatics; chemoinformatics

Call for participations

The members of the Scientific Committee are pleased to announce the Call for Participation for the 7th International Electronic Conference on Medicinal Chemistry and to invite each researcher working in the exciting fields of medicinal chemistry and drug related sciences to share her/his recent results with her/his colleagues all over the world.

The Conference will cover a wide range of aspects involved in drug discovery and development. A non-exhaustive list of topics that will be considered includes:

  • Animal experimentation
  • Assay development
  • Biomarkers
  • Biomolecules
  • Biosensors
  • Biotechnology
  • Chemical synthesis
  • Clinical studies and side effects reports
  • Combinatorial chemistry
  • Drug delivery (including bioconjugates and prodrugs)
  • High throughput screening
  • Hit identification
  • Imaging techniques
  • In silico experiments
  • In vitro and in vivo studies
  • Lead optimization
  • Omics
  • Pharmaceutical analysis
  • Scale-up
  • Structure–activity relationships

Participation in the 7th International Electronic Conference on Medicinal Chemistry is absolutely free of charge for contributors and visitors. Researchers are invited to provide a short abstract (250 words maximum without figure and without references) online at from now until October 18, 2021. A maximum of 3 (three) submissions by each research group (any session combined) will be considered. Acceptance will be notified within a week after submission of the abstract. Then the author(s) will be asked to present their work (in English) in the form of a poster, a slideshow, or a video using the templates provided by the conference (see Instructions for Authors). All accepted submissions will be displayed online, at, on November 1-30, 2021.

Authors will be invited to publish their work as a review or a research article at a discounted price, in a Special Issue of the Journal Pharmaceuticals.

The Scientific Committee looks forward to receiving contributions in response to this Call and will be glad to provide any further information to interested parties. Questions may be addressed to the chairman via e-mail at [email protected] or to the Pharmaceuticals editorial office at [email protected].

We thank you in advance for your attendance of this conference and look forward to a stimulating exchange.

Invited Speakers

Laboratório de Química Orgânica e Farmacêutica, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal; CIIMAR, Centro Interdisciplinar de Investigação Marinha e Ambiental, Universidade do Porto, Porto, Portugal

Foodborne Toxin Detection and Prevention Research Unit, Western Regional Research Center, USDA-ARS, 800 Buchanan St., Albany, CA 94710, USA

AGIR, UR 4294, UFR de pharmacie, Université de Picardie Jules Verne, Amiens, France

CQE, Faculdade de Ciências, Universidade de Lisboa, Portugal

Faculté de médecine, Université Laval, Québec, QC, Canada

Université de Nantes, Cibles et médicaments des infections et du cancer, IICiMed, EA 1155, F-44000, Nantes, France

Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA

Institute of Parasitology and Biomedicine Lopez-Neyra, CSIC PTS Granada, Granada, Spain

Department of Chemical-Technological Science, State University of Novi Pazar, Vuka Karadžiča bb, 36300 Novi Pazar, Serbia

Instructions for Authors

Submission Information
Authors should submit their work online by logging in with and using the "Start New Submission" function once logged into the system.
  • Researchers interested in attending the Conference must submit an abstract of the work they intend to present (maximum 250 words without figures, without references; keywords must be in alphabetical order), no later than 18 October 2021.
  • After the abstract is accepted (1–5 days after receipt of the abstract), the authors will be invited to prepare a full description of their work in the form of a poster, slideshow, or video at their best convenience.
  • Posters must be uploaded as a PDF file using the Poster_template.pptx file available at the end of this section.
  • Slideshows must be uploaded as a PDF file using the PPT_template.pptx file available at the end of this section.
  • Flash communications (5 minutes) and communications (10-20 minutes) must be uploaded as an mp4 file (video) using the PPT_template.pptx file available at the end of this section.
This must be uploaded before 30 October 2021, for a final check and approval. Each work will be directed to the appropriate panel (posters, slideshows, flash communications, communications) by the Conference Office.

Contributions will be displayed on the website using’s proprietary slides viewer and will be accessible at at the time of the conference. They can be prepared in exactly the same way as for any traditional conference where research results can be presented. Contributions must be converted to PDF format before submission, so that they can be easily and automatically converted to be displayed online.
The organization of posters is left completely up to the authors, provided that they use the Conference’s template.

We recommend the following organization for your slideshow or video, using the Conference’s template:

  • Length of the presentation: no more than 30 slides
  • Slide 1 (strictly one slide): Title, authors’ names, affiliation(s), email address of corresponding author, logos of the laboratory and/or institution (not mandatory).
  • Slide 2 (strictly one slide): Graphical abstract; repeat the title of the presentation but avoid other text as far as possible.
  • Slide 3 (strictly one slide): Abstract (max. 250 words) and 3–5 keywords, separated by semicolons.
  • Slide 4 and following slides: These should contain (in the given sequence) Introduction, Results and Discussion, Conclusions.
  • Last slide: Acknowledgments, and logos of sponsors (not mandatory).

Uploaded files:



Event Awards

The following awards will be offered by our sponsors

The Awards
Four travel grants offered by Pharmaceuticals

Number of Awards Available: 4

The open access peer-reviewed Journal Pharmaceuticals will offer one travel grant (400 CHF) to reward the best poster, the best slideshow, the best flash communication, and the best communication. All submissions will be considered, independently of the session (general and round table). The best works will be selected by the members of the Scientific Committee.
One additional travel grant offered by Pharmaceuticals for the best invited lecture

Number of Awards Available: 1

The open access peer-reviewed Journal Pharmaceuticals will offer one travel grant (500 CHF) to reward the best invited lecture, as selected by the members of the Scientific Committee.
One free 1-day hands on/testing using microwaves offered by Microwave Technologies Consulting

Number of Awards Available: 1

One free 1-day hands on/testing using microwaves offered by Microwave Technologies Consulting. Selection will be made by the Company following strict scientific criteria.
One registration seat to an upcoming Simulations Plus workshop

Number of Awards Available: 1

Simulations Plus, Inc., will offer a single registration seat to an upcoming Simulations Plus workshop (valued at 2,000 USD; e.g. Selection will be made by the Company following strict scientific criteria.

Conference Secretariat

Ms. Fendy Fan
Ms. Jennifer Wang
Email: [email protected]

Sponsors and Partners


Media Partners

Exhibition Hall

exhibition hall